Classification position and cellular substrate
Waldenström macroglobulinemia, also known as lymphoplasmacytic lymphoma, is a malignant neoplasm of hematopoietic and lymphoid tissues. It accounts for about 5% of all plasma cell disorders. Epidemiologically, the pathology has a clear profile: the vast majority of patients are men over 50 years of age.
The morphological basis of the tumor is the proliferation of B cells. An important feature of the cellular composition is the heterogeneity of the maturity degree of the elements. The tumor infiltrate simultaneously contains both small lymphocytes and fully differentiated plasma cells. This morphological picture distinguishes the disease from other variants of monoclonal gammopathies.
Immunophenotype and symptom pathogenesis
The key link in pathogenesis is the secretory activity of tumor cells. They produce a specific paraprotein — the M-component. In Waldenström macroglobulinemia, this component is associated with the monoclonal production of immunoglobulin class M (IgM). In extremely rare cases, the tumor may secrete IgA or IgG.
The concentration of IgM in blood serum reaches critical values, ranging from 25 to 80 g/L. Because the macroglobulin molecule has a large mass and size, its excess in the bloodstream inevitably leads to the development of hyperviscosity syndrome. It is this physicochemical shift that determines the severity of the patients' condition and the formation of a specific clinical picture associated with impaired blood rheology.
Clinical presentation and differential diagnosis
Clinical manifestations of Waldenström macroglobulinemia consist of two main syndromes: tumor infiltration and hyperviscosity.
Tumor B cells infiltrate lymph nodes, bone marrow, and spleen. By the nature of the involvement of these organs, the disease strongly resembles other lymphomas. However, there is a crucial differential diagnostic criterion: unlike multiple myeloma or bone forms of solitary plasmacytomas, Waldenström macroglobulinemia shows no bone resorption (osteolysis).
Hyperviscosity syndrome manifests with the following symptoms:
- Neurological disorders: due to central nervous system hypoxia, patients complain of severe dizziness, visual impairment, and the development of paresis.
- Hemorrhagic syndrome: small hemorrhages occur in the mucous membranes. The pathogenesis of these bleeding episodes is twofold: they are caused by both mechanical blood flow disturbance in the microvasculature and secondary platelet dysfunction.
Prognosis and association with other pathologies
The prognosis for lymphoplasmacytic lymphoma remains grave. Patient survival on average does not exceed 5 years.
For a deeper understanding of the pathology, it is important to distinguish it from other B-cell neoplasms. For example, in heavy chain diseases, only immunoglobulin heavy chains (gamma, mu, delta, or alpha) are secreted, which also carries a poor prognosis. In primary immunocyte-associated amyloidosis, tumor B cells produce light chains that partially degrade and deposit in tissues as AL amyloid.
Unlike these conditions, Waldenström macroglobulinemia is characterized by the production of full-length but excessive IgM without the mandatory development of amyloidosis or isolated heavy chain secretion. It is also worth remembering solitary plasmacytomas, which account for 3–5% of monoclonal gammopathies. When located extramedullary (e.g., in the lungs or upper respiratory tract), the disease is curable surgically in combination with chemo- and radiotherapy, whereas lymphoplasmacytic lymphoma is systemic in nature.
Briefly: answers to topical questions
What other B-cell lymphomas must Waldenström macroglobulinemia be differentiated from?
Waldenström macroglobulinemia must be differentiated from multiple myeloma and lymphoplasmacytic lymphoma.
- Multiple myeloma — unlike Waldenström macroglobulinemia, it does not feature bone resorption (osteolysis).
- Lymphoplasmacytic lymphoma — when paraproteins of IgA and IgG classes are secreted, the disease is classified as lymphoplasmacytic lymphoma; Waldenström macroglobulinemia is primarily associated with IgM production.
What specific genetic mutations are detected in tumor cells in Waldenström macroglobulinemia?
Tumor cells in Waldenström macroglobulinemia harbor specific mutations in the MYD88 and CXCR4 genes, which play a key role in the pathogenesis of the disease.
- The p.L265P mutation in the MYD88 gene — is detected in more than 90% of patients. Its absence does not rule out the diagnosis if other clinical and laboratory criteria are present.
- Mutation of the CXCR4 gene — is detected in 30–35% of patients and affects chemokine receptor type 4.
What erythrocyte changes are detected in the peripheral blood smear in Waldenström macroglobulinemia?
The peripheral blood smear in Waldenström macroglobulinemia shows signs of erythrocyte aggregation caused by hyperviscosity syndrome.
- Rouleaux formation — the formation of unstable erythrocyte aggregates due to a decrease in their surface charge under the influence of excess immunoglobulins.
- Erythrocyte sludging — the development of stable cellular aggregation.
These changes are accompanied by a significant acceleration of the erythrocyte sedimentation rate.
What pathomorphological changes occur in the kidneys in Waldenström macroglobulinemia?
In Waldenström macroglobulinemia, renal changes associated with the deposition of pathological proteins may develop.
- Renal amyloidosis — amyloid is deposited in the basement membrane, between the endothelium of renal glomeruli and arterioles, as well as in the basement membrane of renal tubules.
- Monoclonal immunoglobulin deposition — deposition of monoclonal immunoglobulins in renal structures, described in monoclonal gammopathies, including Waldenström macroglobulinemia.
For quick memorization of the clinical picture, use the rule of three "M"s: Men over 50 years old, Monoclonal secretion of Macroglobulin (IgM), Microcirculatory disorders (blood viscosity, paresis, and hemorrhages).
Class and exam questions
Do bones break in Waldenström macroglobulinemia?
No, unlike multiple myeloma, osteolysis (bone tissue resorption) is completely uncharacteristic of this tumor.
Why do patients develop hemorrhages and paresis?
Due to the colossal production of IgM (up to 80 g/L), blood viscosity increases sharply. This disrupts microcirculation, causes nervous tissue hypoxia, and decreases the functional activity of platelets.
Which organs are affected by tumor cells first?
The tumor infiltrate, consisting of B cells of varying degrees of maturity, populates the bone marrow, spleen, and lymph nodes, making the picture similar to other lymphomas.
What else to study on this topic
- Multiple myeloma: development of myeloma nephropathy and secondary AL amyloidosis
- Solitary plasmacytomas: extramedullary lesions and progression risk
- Heavy chain diseases: variants of H-chain secretion and clinical prognosis
- Primary immunocyte-associated amyloidosis: the role of immunoglobulin light chains
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Waldenström macroglobulinemia" and 4,414 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in Hematopoietic System Diseases
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.